Neuron Guard, founded in 2013 and based in Modena, Italy, develops an emergency brain‑protection medical device for patients with Acute Brain Damage (ABD). Its solution comprises a refrigerating collar and a collar control unit that achieves and maintains therapeutic hypothermia of the head district. The company obtained an Italian patent in January 2015 and extended protection to the US, Europe, UAE, Qatar, China, Russia, Brazil, India, Australia, Canada, New Zealand, Japan, and Israel in April 2015. Neuron Guard has raised €656k in funding, with backers including A11 Venture and other private investors, in addition to €250k from founders and €96k from public sources. It intends to use the funds to start production of the first devices in partnership with Italian and international companies and to conduct a pilot study with Cambridge University. The company is seeking additional capital with a target of €2.5m to reach the market within 24 months.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2015